![Lara Sullivan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lara Sullivan
Keine laufenden Positionen mehr
Vermögen: 5 Mio $ am 31.07.2026
Profil
Lara S.
Sullivan was the founder of SpringWorks Therapeutics LLC, founded in 2015, serving as President & Director from 2015 to 2018.
Former jobs include President, CEO, Director & Chief Medical Officer at Pyxis Oncology, Inc. from 2025 to 2026; Director at Rexahn Pharmaceuticals, Inc.; Associate Partner at McKinsey & Co., Inc.; VP-Medical, Worldwide Research & Development at Pfizer Inc. from 2011 to 2017; and Principal at Paul Capital Partners (United Kingdom).
Education includes undergraduate degree from Cornell University, doctorate from Perelman School of Medicine, and MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PYXIS ONCOLOGY, INC. 2,95 % | 20.04.2026 | 1.866.547 ( 2,95 % ) | 5 Mio $ | 31.07.2026 |
Ehemalige bekannte Positionen von Lara Sullivan
| Unternehmen | Position | Ende |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Vorstandsvorsitzender | 03.02.2026 |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company that develops oncology medicines | Gründer | 01.01.2018 |
| PFIZER INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2017 |
Paul Capital Partners (United Kingdom)
 Paul Capital Partners (United Kingdom) Investment ManagersFinance Provides investment consulting services | Corporate Officer/Principal | - |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Ausbildung von Lara Sullivan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
78
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perelman School of Medicine
 Perelman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paul Capital Partners (United Kingdom)
Paul Capital Partners (United Kingdom) Investment ManagersFinance Provides investment consulting services | Finance |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company that develops oncology medicines | Health Technology |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
